PURPLE BIOTECH LTD. (PPBT) Return on equity 2019–2022
PURPLE BIOTECH LTD. (PPBT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.3%FY2022 · since FY2019: 79.0% → -27.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -27.3% | -203.7 pp |
| FY2021 | 176.4% | -89.7 pp |
| FY2020 | 266.1% | +187.1 pp |
| FY2019 | 79.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net incomePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating incomePPBT Operating marginPPBT Operating cash flowPPBT Free cash flowPPBT Capital expendituresPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Total liabilitiesPPBT Shareholders’ equityPPBT overview →